Importantly, a follow-up analysis of patient survival using Kaplan‒Meier curves revealed that high expression of PRKCSH mRNA was correlated with poor first-progression survival and overall survival in patients with lung cancer (Fig. 1d). The gene discussed is PRKCSH; the disease is lung carcinoma.